Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aoxin Q & M Dental GroupSGX:1D4 55 Market Cap is S$277.69 Mil as of Aug. 01, 2026. GuruFocus rates SGX:1D4 with a GF Score™ of 55/100 and a GF Value™ of S$0.05 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 693 Healthcare Providers & Services companies, Aoxin Q & M Dental Group ranks better than 61.04% on this metric.
Aoxin Q & M Dental Group's quarterly market cap
declined
from Dec. 2024 (S$23.02 Mil) to Jun. 2025 (S$22.51 Mil) but then
increased
from Jun. 2025 (S$22.51 Mil) to Dec. 2025 (S$171.87 Mil).
Aoxin Q & M Dental Group's annual market cap
declined
from Dec. 2023 (S$31.70 Mil) to Dec. 2024 (S$23.02 Mil) but then
increased
from Dec. 2024 (S$23.02 Mil) to Dec. 2025 (S$171.87 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aoxin Q & M Dental Group's Enterprise Value for Today is S$251.83 Mil.
Aoxin Q & M Dental Group (SGX:1D4) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Aoxin Q & M Dental Group Market Cap Related Terms
Aoxin Q & M Dental Group Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Aoxin Q & M Dental Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aoxin Q & M Dental Group Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aoxin Q & M Dental Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Aoxin Q & M Dental Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Aoxin Q & M Dental Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aoxin Q & M Dental Group (SGX:1D4) has a Market Cap of S$277.69 Mil as of Aug. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aoxin Q & M Dental Group and its competitors. According to the industry distribution chart, Aoxin Q & M Dental Group ranks #270 out of 693 companies in the Healthcare Providers & Services industry, placing it in the top 39%.
Is Aoxin Q & M Dental Group's Market Cap too high?
Aoxin Q & M Dental Group's current Market Cap is S$277.69 Mil. Based on the distribution chart, Aoxin Q & M Dental Group ranks #270 out of 693 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Aoxin Q & M Dental Group has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aoxin Q & M Dental Group's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aoxin Q & M Dental Group ranks #270 out of 693 companies for Market Cap. This puts Aoxin Q & M Dental Group in the upper half of its industry. The industry median Market Cap is 104.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 104.15, based on 693 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aoxin Q & M Dental Group and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 104.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aoxin Q & M Dental Group's current Market Cap is S$277.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxin Q & M Dental Group stock overvalued right now?
Based on GuruFocus' analysis, Aoxin Q & M Dental Group (SGX:1D4) is currently considered Significantly Overvalued. The stock's GF Value™ is S$0.05, compared to a current price of S$0.24 — trading 380% above its estimated fair value. The current Market Cap is S$277.69 Mil. Aoxin Q & M Dental Group's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Aoxin Q & M Dental Group (SGX:1D4), the current Market Cap is S$277.69 Mil as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aoxin Q & M Dental Group (SGX:1D4) Overvalued in 2026?
Based on GuruFocus' analysis, Aoxin Q & M Dental Group stock appears to be overvalued.
The current stock price of S$0.24 is trading 380% above its estimated GF Value™ of S$0.05.
GuruFocus considers Aoxin Q & M Dental Group to be Significantly Overvalued.
Key valuation signals for SGX:1D4:
Market Cap: S$277.69 Mil
GF Value™: S$0.05 vs. price of S$0.24 (380% above fair value)
No single metric tells the full story. See the SGX:1D4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aoxin Q & M Dental Group Ltd, along with its subsidiaries, offers private dental services, dental equipment, and supplies. The various dental care services offered by the Group include Stomatology and general dentistry, Endodontics, Orthodontics, Periodontics, Dental implantology, and many more. Its dental equipment and supplies portfolio includes dental chairs, ultrasound scanners, dental instruments, materials, and consumables for dental hospitals, clinics, distributors, and laboratories. The Group's reportable operating segments are: Primary healthcare, which generates the maximum revenue, Distribution of dental equipment and supplies, and Laboratory services. Geographically, it generates maximum revenue from the People's Republic of China (PRC) and the rest from Singapore.
55GF Score
Get the complete analysis for SGX:1D4
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1D4 has been successfully added to your 
